^ Interesting sentiment there Sidage. I concur.
However, there is a question of how much should each patient be worth in future revenues?
Balance Sheets tell us certainly not enough to warrant this high a MC, so what is the acceptable sort of metric to value these patients?
AFAIK AGH has 1500+ patients, likely closing in on 2000 now. Is that worth 150-200M MC? Obviously partnering with CannVaLate is huge and the reason why patient growth is so exponential.
If anyone would like to share their valuation metrics here would be welcome to hear it.
Add to My Watchlist
What is My Watchlist?
